Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,753,529
+$2,407,873 QoQ
Shares Held
179,423
+18.1% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Derivatives in TNGX
reported options exposure · as of Mar 31, 2026CallValue
$1,010,436
CallShares
48,300
PutValue
$464,424
PutShares
22,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. TNGX ranks #152 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in TNGX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $464,424 | 22,200 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,010,436 | 48,300 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $3,753,529 | 179,423 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,345,656 | 151,880 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $102,776 | 11,600 | Call | Defined | 2026-02-17 | |
| 2025-06-30 | $82,944 | 16,200 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $281,932 | 55,065 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,507 | 1,100 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $145,907 | 106,502 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,596 | 4,400 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $5,026,685 | 1,626,759 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $4,326 | 1,400 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $11,550 | 1,500 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $23,870 | 3,100 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $20,744,762 | 2,694,125 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,568,475 | 1,231,757 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $8,580 | 1,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $22,308 | 2,600 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $12,704 | 1,600 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $3,700,976 | 466,118 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $15,880 | 2,000 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $1,997,967 | 201,815 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $4,950 | 500 | Call | Defined | 2024-02-14 | |
| 2023-06-30 | $547,753 | 164,986 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $683,594 | 173,062 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,649,041 | 365,385 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,731,315 | 478,264 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,876,303 | 414,195 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,018,241 | 398,185 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,045,899 | 461,234 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,282,228 | 408,525 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||